TARSUS PHARMACEUTICALS, INC.: cashflow_investing
| Value | {"amount": 75386000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-06-30 |
| Status | current |
| Entity | TARSUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2c79fcd8-1334-4304-b1a3-152941c19bb8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001819790-23-000071Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001819790/cashflow-investing/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2c79fcd8-1334-4304-b1a3-152941c19bb8
History
- no predecessors — first report